Effects of angiotensin II blockade on nitric oxide blood levels in IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 15, Issue 7, 2000, Pages 988-993

  Roccatello, Dario ^a   Mengozzi, Giulio ^b   Gigliola, Graziella ^b   Rossi, Daniella ^a   Mosso, Roberto ^c   Cacace, Giovanni ^c   Polloni, Renato ^c   Cesano, Giulio ^b   Picciotto, Giuseppe ^c   Paradisi, Luciana ^b   Bancale, Enrico ^d   Piccoli, Giuseppe ^b   Sena, Luigi M ^b  

^a Ospedale L Einaudi   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d S GIOVANNI BOSCO HOSPITAL   (Italy)

Author keywords

Angiotensin receptor antagonists; Haemodynamics; IgA nephropathy; Nitric oxide

Indexed keywords

ALDOSTERONE; ANGIOTENSIN RECEPTOR; ENALAPRIL; HEMOGLOBIN; ISOSORBIDE 5 NITRATE; KININ; LOSARTAN; NITRIC OXIDE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY PLASMA FLOW; MALE; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URINE LEVEL;

EID: 0034124137     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.7.988     Document Type: Article

References (37)

1. Vos PF, Boer P, Koomans HA. Effects of enalapril on renal sodium handling in healthy subjects on low, intermediate, and high sodium intake. J Cardiovasc Pharmacol 1993; 22: 27-32
2. Burnier M, Rutschmann B, Nussberger J et al. Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects. Hypertension 1993; 22: 339-347
3. Gansevoort RT, Zeeuw DD, Jong PED. Is the antiproteinuric effect of ACE inhibition mediated by interference with the renin angiotensin system? Kidney Int 1994; 45: 861-867
4. Braam B, Koomans HA. Renal responses to antagonism of the renin-angiotensin system. Curr Opin Nephrol Hypertens 1996; 5: 89-96
5. Gavras I. Bradykinin-mediated effects of ACE-inhibition. Kidney Int 1992; 42: 1020-1029
6. Roccatello D, Mengozzi G, Alfieri V et al. Early increase in blood nitric oxide, detected by electron paramagnetic resonance as nitrosylhaemoglobin, in haemodialysis. Nephrol Dial Transplant 1997; 12: 292-297
7. Buckhof JR, Kardaun O, Schaafsma W et al. Toward individual prognosis of IgA nephropathy. Kidney Int 1986; 29: 549-556
8. Hotta O, Yoshizawa N, Oshima S et al. Significance of renal hyaline arteriolosclerosis and tubulo-interstitial changes in IgA glomerulonephropathy and focal glomerular sclerosis. Nephron 1987; 47: 262-265
9. Neelakantappa K, Gallo GR, Baldwin DS. Proteinuria in IgA nephropathy. Kidney Int 1988; 33: 716-721
10. Hiraoka-Yoshimoto M, Higashida K, Takeda M, Kawamoto S, Ichikawa I, Hoover RL. Characterization of myosin heavy and light chains in cultured mesangial cells. Kidney Int 1991; 40: 1013-1019
11. Stein HD, Feddergreen W, Kashgarian M, Sterzel RB. Role of angiotensin II-induced renal functional changes in mesangial deposition of exogenous ferritin in rats. Lab Invest 1983; 49: 270-280
12. Raji L, Keane WF. Glomerular mesangium: Its function and relationship to angiotensin II. Am J Med 1985; 79: 24-30
13. Navar GL, Rosivall L. Contribution of the renin angiotensin system to the control of intrarenal hemodynamics. Kidney Int 1984; 25: 857-868
14. Remuzzi A, Perticucci E, Ruggenenti P, Mosconi L, Limonta M, Remuzzi G. Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 1991; 39: 1267-1273
15. Lapinski R, Perico N, Remuzzi A, Sangalli F, Benigni A, Remuzzi G. Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney. J Am Soc Nephrol 1996; 7: 653-660
16. Coppo R, Amore A, Giagnoglio B et al. Angiotensin II local hyperreactivity in the progression of IgA nephropathy. Am J Kidney Dis 1993; 21: 593-602
17. Jaffer FE, Knauss TC, Poptic E, Abboud HE. Endothelin stimulates PDGF secretion in cultured human mesangial cells. Kidney Int 1990; 38: 1193-1198
18. Roccatello D, Mosso R, Ferro M et al. Urinary endothelin in glonerulonephritis patients with normal renal function. Clin Nephrol 1994; 41: 223-230
19. Roccatello D, Mengozzi G, Ferro M et al. Isosorbide 5 mononitrate administration increases nitric oxide blood levels and reduces proteinuria in IgA glomerulonephritis patients with abnormal urinary endothelin/cyclic GMP ratio. Clin Nephrol 1995; 44: 163-169
20. Furchgott RF, Zadawski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376
21. Raij L, Shultz PJ. Endothelium-derived relaxing factor, nitric oxide: effects on and production by mesangial cells and the glomerulus. J Am Soc Nephrol 1993; 3: 1435-1441
22. Galla JH. IgA nephropathy. Kidney Int 1995; 47: 377-387
23. Johnston CL. Angiotensin receptor antagonists: focus on losartan. Lancet 1995: 346: 1403-1407
24. Mengozzi G, Paradisi L, Inconis T et al. Guanylate cyclase activity in human peripheral mononuclear leucocytes and detection of plasma nitric oxide-heme complex through electron spin resonance. A comparative study in normotensive and hypertensive subjects. In: Moncada S, Feelisch M, Busse R, Higges A, eds. Biology of Nitric Oxide. London Portland Press, 1994; 506-509
25. 51CR-EDTA plasma clearance. A comparative assessment of simplified techniques. Eur J Nucl Med 1992; 19: 30-35
26. Tauxe WN, Dubovsky EV, Kidd T. New formulae for the calculation of effective renal plasma flow by the single plasma sample method. Eur J Nucl Med 1982; 7: 51-54
27. Kon V, Fogo A, Ichikawa I. Bradykinin causes selective effrent arteriolar dilation during angiotensin II converting enzyme inhibition. Kidney Int 1993; 44: 545-550
28. Tanaka R, Kon V, Yoshioka T, Ichikawa I, Fogo A. Angiotensin converting enzyme inhibitor modulates glomerular filtration and structure by distinct mechanism. Kidney Int 1994; 45: 537-543
29. Lafajette RA, Mayer G, Park SK, Meyer TW. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992; 90: 766-771
30. Gansevoort RT, de Zeeuw D, Shahinfar S, Redfield A, de Jong PE. Effects of the angiotensin II antagonist losartan in hypertensive patients. J Hypertens 1994; 12 [Suppl 2]: S37-42
31. Gavras I. Bradykinin-mediated effects of ACE inhibition. Kidney Int 1992; 42: 1020-1029
32. Fogo A, Yoshida Y, Glick AD, Homma T, Ichikawa J. Serial micropuncture analysis of glomerular function in two rats models of glomerular sclerosis. J Clin Invest 1988; 82: 322-330
33. Fogo A, Ichikawa J. Glomerular growth promoter-the common channel to glomerular sclerosis. In: Mitch WE, ed. The Progressive Nature of Renal Disease, 2nd edn. Churchill Livingstone, New York, 1992; 23-54
34. Ichikawa I. Will angiotensin II receptor antagonists be renoprotective in humans? Kidney Int 1996; 50: 684-692
35. Ichiki T, Labosky PA, Shiota C et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377: 748-750
36. Siragy UM, Carey RM. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 1997; 100: 264-269
37. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counterregulatory actions of angiotensin (1-7). Hypertension 1997; 30: 535-541